Company Filing History:
Years Active: 2013-2016
Title: Claire June Flynn: Innovator in Protein Kinase Inhibitors
Introduction
Claire June Flynn is a prominent inventor based in Angus, GB. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of pyrimidine derivatives as protein kinase inhibitors. With a total of 3 patents to her name, Flynn's work is paving the way for advancements in the treatment of proliferative disorders.
Latest Patents
Flynn's latest patents focus on pyrimidine derivatives that are capable of inhibiting one or more protein kinases. The first patent describes these derivatives and their pharmaceutical compositions, emphasizing their potential use in treating proliferative disorders. The second patent further elaborates on a specific compound formula, detailing its various components and their roles in the inhibition process. These innovations highlight her commitment to addressing critical health challenges through her research.
Career Highlights
Claire June Flynn is currently associated with Cyclacel Limited, where she continues to advance her research in the pharmaceutical sector. Her work has garnered attention for its potential impact on medical treatments, particularly in oncology and related fields.
Collaborations
Flynn collaborates with notable colleagues, including Jonathan James Hollick and Stuart Donald Jones. Their combined expertise contributes to the innovative research environment at Cyclacel Limited.
Conclusion
Claire June Flynn stands out as a dedicated inventor whose work in protein kinase inhibitors is making a significant impact in the pharmaceutical industry. Her contributions are essential for the development of new treatments for proliferative disorders.